• OPEN AN ACCOUNT
Indian Indices
Sensex
78,079.96 113.61
( 0.15%)
Global Indices
Nasdaq
53,790.86 -21.99
(-0.04%)
Dow Jones
7,769.71 20.51
(0.26%)
Hang Seng
68,341.16 817.10
(1.21%)
Nikkei 225
10,757.72 -75.43
(-0.70%)
Forex
USD-INR
95.38 0.10
(0.10%)
EUR-INR
110.06 0.02
(0.01%)
GBP-INR
128.81 0.17
(0.13%)
JPY-INR
0.60 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Ruparel Food Products Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
511740
INE239B01014
15.2887735
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
40.45
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

maruti suzuki india ltd
Jenburkt Pharmaceuticals standalone net profit rises 27.05% in the March 2026 quarter
May 06,2026
Net profit of Jenburkt Pharmaceuticals rose 27.05% to Rs 10.85 crore in the quarter ended March 2026 as against Rs 8.54 crore during the previous quarter ended March 2025. Sales rose 8.72% to Rs 44.63 crore in the quarter ended March 2026 as against Rs 41.05 crore during the previous quarter ended March 2025.

For the full year,net profit rose 8.36% to Rs 34.74 crore in the year ended March 2026 as against Rs 32.06 crore during the previous year ended March 2025. Sales rose 11.24% to Rs 168.74 crore in the year ended March 2026 as against Rs 151.69 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales44.6341.05 9 168.74151.69 11
OPM %31.9326.46 -25.9226.63 -
PBDT18.4712.63 46 53.5846.66 15
PBT17.6611.84 49 50.4743.93 15
NP10.858.54 27 34.7432.06 8